Headlines National

Serum Institute para aro bi 100 million COVID-19 vaccine doses olabo

NEW DELHI | SEPT 30, 2020: Serum Institute of India (SII), khan Tuesday te koishe ki tai khan para aro bi 100 million COVID-19 vaccine india  aro low-and middle-income countries (LMICs) Gavi aro Bill and Melinda Gates Foundation te olabo.

SII  statement  te koishe  Etu  latest collaboration   partners khan majhotte       vaccine  doses laga  number toh cover kuribole nimete thaka  toh    200 million doses uporte hoijaishe.

August te SII  khan  ekta nutun partnership olaishe   international vaccine alliance Gavi aro Bill and Melinda Gates Foundation logote      etu  olabole  aro 100 million doses COVID-19 vaccines dibole nimete.

Etu collaboration para  upfront capital SII ke dibo    capacity toh uthabole  nimete etia  etu para ekbar vaccine toh regulatory approval paishe koile toh     aro WHO Prequalification para etu  toh LMICs khan ke dibole paribo.

Tai khan  etu doses toh Gavi COVAX AMC mechanism toh 2021 laga first half te joldi dibo.Bill & Melinda Gates Foundation, via its Strategic Investment Fund ppara    funding toh arobi USD 150 million Gavi ke dibo etu para total funding   diya  toh collaboration para USD 300 million te uthibo.

Etu para  SII ke support kuribo etu  potential vaccine candidates olabole nimete aro   vaccine laga  future  procurement   aro low-and middle-income countries khan nimete bi.

Etu funding  para modot kuribo SII potential vaccine candidates   AstraZeneca and Novavax para license diya toh    kuntu toh procurement nimete thakibo judi tai khan  successful hoishe  koile toh   full license aro WHO Prequalification pabole  nimete.

Etu vaccine toh ceiling price of USD 3 per dose thakibo etu toh ekta  price ase investment  para ola toh partners khan  etu te Coalition for Epidemic Preparedness Innovations (CEPI), the Bill & Melinda Gates Foundation aro SII ola toh.

Gavi, SII, and the Gates Foundation khan  majhotte  collaboration para  the ACT Accelerator’s vaccines pillar, COVAX, laga  kaam te  support kurishe  Gavi, CEPI and the World Health Organization (WHO), etu COVID-19 vaccines toh joldi olabole  nimete aro joldi hi etu access kuribole  nimete.

Decision toh investment  nimete  manufacturing  nimete    etu tinta lead organisation COVAX pillar majhotte collaboration nimete hoishe.

COVAX umbrella, bithor te Gavi toh  COVAX facility logote mili ase   kun para government khan ke ekta opportunity dishe    laaph pabole nimete large portfolio para COVID-19 candidate vaccines laga   technology platforms  khan chulaikena.

Etia tak 73 higher-income economies khan commit kurishe etu facility te ahibole  nimete etu ekla nohoikena  etu 92 low-and middle-income economies khan elgible   hoishe  Gavi COVAX AMC para support pabole nimete.